Immunosuppressive drug (Sandimmune) reimbursement
Transplant patients will be reimbursed the cost of immunosuppressive agents, such as Sandoz' Sandimmune (cyclosporine), for one year under a House-Senate conference committee agreement on fiscal 1987 budget reconciliation legislation. Agreement on health portions of the bill was reached early in October, but final action could not be taken until conferees arrived at a compromise on the entire package.
You may also be interested in...
Join us for an audio catch-up on the latest key developments in the global biopharma industry, as reported by Scrip's global team, in this mini podcast version of Five Must-Know Things.
California proposes limiting short-form Prop 65 warnings to products with 5 inches or less of labeling space, while prohibiting their use in online and catalog warnings. The number of products with the warnings, used even on vacuum cleaners, luggage and guitars, has made tracking them impossible.
While endocrine-disrupting evidence was inconclusive, the Scientific Committee on Consumer Safety recommends more conservative limits on use of homosalate, octocrylene and benzophenone-3 in cosmetic products compared with current requirements under the European Cosmetics Product Regulation.